Showing Latest Articles
Etanercept use associated with significant increases in height, weight, BMI in children with arthritis Full Text
Formulary , 01/27/2011
Clinical Article
Researchers from the Cincinnati Children's Hospital Medical Center have demonstrated that the tumor necrosis factor (TNF)–alpha inhibitor etanercept is associated with significant increases in height, weight, and body mass index (BMI) in children with juvenile idiopathic arthritis (JIA), according to a study recently published in Arthritis & Rheumatism. Further, these benefits were apparent regardless of whether methotrexate was used concomitantly.